EGAGenomicsWhole Genome Sequencinghttps://ega-archive.org/studies/EGAS00001007084EGAEGA study EGAS00001007084sWGS data of Pap test smears and tumor tissuesEGArestrictedDmelCG5212, PDCD9, DmelCG9936, 2.7.7.19, Plap-ps, Neoplasms, Benign Neoplasm, pulmonary alveolar proteinosis autoimmune, REG3, Tumor, Paxillin-associated protein with ARF GAP activity 3, Malignant, 5'-NT, PDGFA-associated protein 1, Lgcc, 6530401G17Rik, ACP-3, PAP acquired, Skd/Pap/Bli, REG-III, pulmonary alveolar lipoproteinosis acquired, CG9854, Skd/Med13, S30mt, PapIII, simple tissue., dTrap240, Malignancy, mtPAP, PAP-associated domain-containing protein 1, PAPf39, Tissue, Pap-alpha, Gm592, Gm1523, pap/dTRAP240, ZG14P, PPT, INGAP, PAG3, PAG2, Polynucleotide adenylyltransferase, 3.1.3.2, l(2)07619, bli, Trap240, Transplant Donors, SPH203, Neoplasias, PDGF-associated protein, l(3)L7062, bls, C3orf11, Development and differentiation-enhancing factor 2, FUS1, Fus1, Clients, l(3)rK760, HIP, siren9, Plap, pulmonary alveolar proteinosis, Paplob, pulmonary alveolar lipoproteinosis, Tissue Donor, Malignancies, Ovum Donor, Papola-ps, pulmonary alveolar proteinosis acquired, PAP, Pap, Organ, Cancer, Tumors, AMAP2, AMAP1, AA968347, DmelCG9854, Transplant Donor, Malignant Neoplasm, TUTase 1, mKIAA1249, Pyk2 C-terminus-associated protein, 5'-nucleotidase, Transplant, AV239055, MED13, Semen Donors, DEF-1, ACP3, CENTB3, Client, acquired, pap, CENTB4, HASPP28, AA407686, Med13, autoimmune, TMPase, 3.1.3.5, Benign, dmMED13, Pap/Trap, CG9936, Neoplasm, 2610020A16Rik, CG5212, Donor, Donors, PBCGF, PAP1, papola-B, Thiamine monophosphatase, Ecto-5'-nucleotidase, l(2)k07619, MRP-S30, LD28662, Organ Donor, TRAP240, 1190001E22Rik, Benign Neoplasms, Cancers, Pdap2, s19, dTRAP240, Semen Donor, Malignant Neoplasms, Srb9/AMIB/PAP/TRAP240, SHAG1, Semen, PDAP2, dMED13, Patient, Tpap, Skd, DDEF1, DDEF2, Papt, Pdcd9, acquired pulmonary alveolar proteinosis, Scad78, other neoplasm, Ovum, Ovum Donors, Organ Donors, PAP-H, Ddef2, Neoplasia, Ddef1, Terminal uridylyltransferase 1DmelCG5212, PDCD9, DmelCG9936, Antemortem Diagnosis, 2.7.7.19, Plap-ps, Neoplasms, Benign Neoplasm, pulmonary alveolar proteinosis autoimmune, REG3, Tumor, Paxillin-associated protein with ARF GAP activity 3, Malignant, Diagnosis, 5'-NT, PDGFA-associated protein 1, Lgcc, 6530401G17Rik, ACP-3, PAP acquired, Skd/Pap/Bli, primary tumour, REG-III, Girls, Mass, symptoms, Screening, pulmonary alveolar lipoproteinosis acquired, CG9854, Skd/Med13, Antemortem, S30mt, PapIII, Complete, Whole Genome, dTrap240, Malignancy, mtPAP, PAP-associated domain-containing protein 1, PAPf39, Complete Genome Sequencing, Pap-alpha, Gm592, Gm1523, pap/dTRAP240, ZG14P, PPT, INGAP, PAG3, Diagnoses and Examinations, PAG2, Polynucleotide adenylyltransferase, 3.1.3.2, Sequencing, l(2)07619, bli, Trap240, SPH203, Neoplasias, PDGF-associated protein, l(3)L7062, bls, C3orf11, Development and differentiation-enhancing factor 2, FUS1, Fus1, Clients, Whole, l(3)rK760, sample, HIP, siren9, Plap, pulmonary alveolar proteinosis, Paplob, pulmonary alveolar lipoproteinosis, malignant ovarian serous tumour, Malignancies, serous ovarian cancer, Papola-ps, pulmonary alveolar proteinosis acquired, Diagnose, PAP, Pap, Cancer, Tumors, AMAP2, AMAP1, Antemortem Diagnoses, screening, AA968347, DmelCG9854, findings, Malignant Neoplasm, TUTase 1, mKIAA1249, Pyk2 C-terminus-associated protein, 5'-nucleotidase, Women's Group, Women Groups, Genome Sequencing, AV239055, MED13, DEF-1, ACP3, CENTB3, Woman, Client, Girl, Examination and Diagnoses, acquired, pap, CENTB4, Diagnoses, HASPP28, AA407686, Med13, autoimmune, TMPase, 3.1.3.5, Complete Genome, Benign, Postmortem, Screenings, dmMED13, Pap/Trap, Mass Screenings, Examinations and Diagnoses, CG9936, Neoplasm, 2610020A16Rik, CG5212, PBCGF, PAP1, papola-B, Postmortem Diagnosis, Thiamine monophosphatase, Ecto-5'-nucleotidase, Diagnoses and Examination, l(2)k07619, MRP-S30, Postmortem Diagnoses, Terminal uridylyltransferase 1., LD28662, primary neoplasia, TRAP240, Women's Groups, 1190001E22Rik, signs, Benign Neoplasms, Cancers, Pdap2, s19, dTRAP240, sample population, Malignant Neoplasms, Srb9/AMIB/PAP/TRAP240, SHAG1, PDAP2, dMED13, Patient, primary tumor, Tpap, Skd, DDEF1, DDEF2, Papt, Pdcd9, acquired pulmonary alveolar proteinosis, Scad78, other neoplasm, PAP-H, Ddef2, Neoplasia, Ddef1, Terminal uridylyltransferase 1falsesWGS of Pap test smears from healthy donors and HGSOC patients and matched tumor tissueShallow whole genome sequencing was performed on Pap test smears considering at least 10 M reads per sample. The cohort consists of 77 samples from healthy women, i.e. no tumor diagnosis, and 65 samples from women with a diagnosis of high-grade serous ovarian cancer (HGSOC) taken months or years before diagnosis. 44 primary tumor samples matched to the respective HGSOC patients were sequenced in the same manner as the Pap test smears.2023-12-12 14:33:40EGAS000010070849606EGAD00001010141EGAC00001002915